126 related articles for article (PubMed ID: 7689595)
1. Presentation of endogenous acetylcholine receptor epitope by an MHC class II-transfected human muscle cell line to a specific CD4+ T cell clone from a myasthenia gravis patient.
Baggi F; Nicolle M; Vincent A; Matsuo H; Willcox N; Newsom-Davis J
J Neuroimmunol; 1993 Jul; 46(1-2):57-65. PubMed ID: 7689595
[TBL] [Abstract][Full Text] [Related]
2. T-helper epitopes on human nicotinic acetylcholine receptor in myasthenia gravis.
Moiola L; Protti MP; Manfredi AA; Yuen MH; Howard JF; Conti-Tronconi BM
Ann N Y Acad Sci; 1993 Jun; 681():198-218. PubMed ID: 7689306
[TBL] [Abstract][Full Text] [Related]
3. Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexes.
Nicolle MW; Nag B; Sharma SD; Willcox N; Vincent A; Ferguson DJ; Newsom-Davis J
J Clin Invest; 1994 Apr; 93(4):1361-9. PubMed ID: 7512979
[TBL] [Abstract][Full Text] [Related]
4. Myasthenia gravis. T epitopes on the delta subunit of human muscle acetylcholine receptor.
Protti MP; Manfredi AA; Wu XD; Moiola L; Howard JF; Conti-Tronconi BM
J Immunol; 1991 Apr; 146(7):2253-61. PubMed ID: 1706391
[TBL] [Abstract][Full Text] [Related]
5. Immuno-suppressive peptides for a human T cell clone autoreactive to a unique acetylcholine receptor alpha subunit peptide presented by the disease-susceptible HLA-DQ6 in infant-onset myasthenia gravis.
Kanai T; Nomura Y; Segawa M; Takagi K; Senju S; Matsushita S; Nishimura Y
Hum Immunol; 1997; 56(1-2):28-38. PubMed ID: 9455491
[TBL] [Abstract][Full Text] [Related]
6. CD4+ T-epitope repertoire on the human acetylcholine receptor alpha subunit in severe myasthenia gravis: a study with synthetic peptides.
Manfredi AA; Protti MP; Wu XD; Howard JF; Conti-Tronconi BM
Neurology; 1992 May; 42(5):1092-100. PubMed ID: 1374548
[TBL] [Abstract][Full Text] [Related]
7. B-T lymphocyte interactions in experimental autoimmune myasthenia gravis: antigen presentation by rat/mouse hybridoma lines secreting monoclonal antibodies against the nicotinic acetylcholine receptor.
Zhang YP; Tzartos SJ; Wekerle H
Eur J Immunol; 1988 Feb; 18(2):211-8. PubMed ID: 2450756
[TBL] [Abstract][Full Text] [Related]
8. The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptor.
Bellone M; Ostlie N; Lei SJ; Wu XD; Conti-Tronconi BM
J Immunol; 1991 Sep; 147(5):1484-91. PubMed ID: 1715360
[TBL] [Abstract][Full Text] [Related]
9. Myasthenia gravis. CD4+ T epitopes on the embryonic gamma subunit of human muscle acetylcholine receptor.
Protti MP; Manfredi AA; Wu XD; Moiola L; Dalton MW; Howard JF; Conti-Tronconi BM
J Clin Invest; 1992 Oct; 90(4):1558-67. PubMed ID: 1383275
[TBL] [Abstract][Full Text] [Related]
10. Preferential use of a T cell receptor V beta gene by acetylcholine receptor reactive T cells from myasthenia gravis-susceptible mice.
Infante AJ; Levcovitz H; Gordon V; Wall KA; Thompson PA; Krolick KA
J Immunol; 1992 Jun; 148(11):3385-90. PubMed ID: 1375242
[TBL] [Abstract][Full Text] [Related]
11. T-cell recognition of muscle acetylcholine receptor subunits in generalized and ocular myasthenia gravis.
Wang ZY; Okita DK; Howard J; Conti-Fine BM
Neurology; 1998 Apr; 50(4):1045-54. PubMed ID: 9566393
[TBL] [Abstract][Full Text] [Related]
12. Human acetylcholine receptor presentation in myasthenia gravis. DR restriction of autoimmune T epitopes and binding of synthetic receptor sequences to DR molecules.
Manfredi AA; Yuen MH; Moiola L; Protti MP; Conti-Tronconi BM
J Immunol; 1994 Apr; 152(8):4165-74. PubMed ID: 7511671
[TBL] [Abstract][Full Text] [Related]
13. Presentation by myoblasts of an epitope from endogenous acetylcholine receptor indicates a potential role in the spreading of the immune response.
Curnow J; Corlett L; Willcox N; Vincent A
J Neuroimmunol; 2001 Apr; 115(1-2):127-34. PubMed ID: 11282162
[TBL] [Abstract][Full Text] [Related]
14. A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4- producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes.
Nagvekar N; Moody AM; Moss P; Roxanis I; Curnow J; Beeson D; Pantic N; Newsom-Davis J; Vincent A; Willcox N
J Clin Invest; 1998 May; 101(10):2268-77. PubMed ID: 9593783
[TBL] [Abstract][Full Text] [Related]
15. Anti-acetylcholine receptor (AChR) antibodies measurement in myasthenia gravis: the use of cell line TE671 as a source of AChR antigen.
Somnier FE
J Neuroimmunol; 1994 Apr; 51(1):63-8. PubMed ID: 8157737
[TBL] [Abstract][Full Text] [Related]
16. Genetic restriction of autoreactive acetylcholine receptor-specific T lymphocytes in myasthenia gravis.
Hohlfeld R; Conti-Tronconi B; Kalies I; Bertrams J; Toyka KV
J Immunol; 1985 Oct; 135(4):2393-9. PubMed ID: 2411794
[TBL] [Abstract][Full Text] [Related]
17. Determinant selection in murine experimental autoimmune myasthenia gravis. Effect of the bm12 mutation on T cell recognition of acetylcholine receptor epitopes.
Infante AJ; Thompson PA; Krolick KA; Wall KA
J Immunol; 1991 May; 146(9):2977-82. PubMed ID: 1707927
[TBL] [Abstract][Full Text] [Related]
18. MHC class II presentation of human acetylcholine receptor in Myasthenia gravis: binding of synthetic gamma subunit sequences to DR molecules.
Yuen MH; Macklin KD; Conti-Fine BM
J Autoimmun; 1996 Feb; 9(1):67-77. PubMed ID: 8845056
[TBL] [Abstract][Full Text] [Related]
19. TCR V beta usage by acetylcholine receptor-specific CD4+ T cells in myasthenia gravis.
Raju R; Navaneetham D; Protti MP; Horton RM; Hoppe BL; Howard J; Conti-Fine BM
J Autoimmun; 1997 Apr; 10(2):203-17. PubMed ID: 9185882
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic and functional characterization of T cells from patients with myasthenia gravis.
Mokhtarian F; Pino M; Ofosu-Appiah W; Grob D
J Clin Invest; 1990 Dec; 86(6):2099-108. PubMed ID: 1979338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
